HKD 3.58
(-0.56%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 397 Thousand USD | -43.69% |
2022 | 705 Thousand USD | 892.96% |
2021 | 71 Thousand USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 88 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 FY | 397 Thousand USD | -43.69% |
2023 Q1 | - HKD | 0.0% |
2023 Q2 | - HKD | 0.0% |
2023 Q3 | - HKD | 0.0% |
2022 FY | 705 Thousand USD | 892.96% |
2022 Q4 | - HKD | 0.0% |
2022 Q3 | - HKD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | -4.76 Million USD | 0.0% |
2021 FY | 71 Thousand USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2019 FY | 88 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 99.899% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 99.958% |